Borrás C - Search Results

1

[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b].

Río J, Marzo ME, Tintoré M, Borrás C, Montalbán X. Río J, et al. Among authors: borras c. Neurologia. 1998 Nov;13(9):422-6. Neurologia. 1998. PMID: 9883016 Clinical Trial. Spanish.

2

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.

Río J, Nos C, Tintoré M, Borrás C, Galán I, Comabella M, Montalban X. Río J, et al. Among authors: borras c. Ann Neurol. 2002 Oct;52(4):400-6. doi: 10.1002/ana.10290. Ann Neurol. 2002. PMID: 12325067 Clinical Trial.

3

Amelioration of flulike symptoms at the onset of interferon beta-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction.

Martínez-Cáceres EM, Río J, Barrau M, Durán I, Borrás C, Tintoré M, Montalban X. Martínez-Cáceres EM, et al. Among authors: borras c. Ann Neurol. 1998 Oct;44(4):682-5. doi: 10.1002/ana.410440415. Ann Neurol. 1998. PMID: 9778268 Clinical Trial.

4

Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.

Borràs C, Río J, Porcel J, Barrios M, Tintoré M, Montalban X. Borràs C, et al. Neurology. 1999 May 12;52(8):1636-9. doi: 10.1212/wnl.52.8.1636. Neurology. 1999. PMID: 10331691

5

Long-term emotional state of multiple sclerosis patients treated with interferon beta.

Porcel J, Río J, Sánchez-Betancourt A, Arévalo MJ, Tintoré M, Téllez N, Borràs C, Nos C, Montalbán X. Porcel J, et al. Among authors: borras c. Mult Scler. 2006 Dec;12(6):802-7. doi: 10.1177/1352458506070748. Mult Scler. 2006. PMID: 17263010

6

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.

Montalban X, Sastre-Garriga J, Tintoré M, Brieva L, Aymerich FX, Río J, Porcel J, Borràs C, Nos C, Rovira A. Montalban X, et al. Among authors: borras c. Mult Scler. 2009 Oct;15(10):1195-205. doi: 10.1177/1352458509106937. Epub 2009 Sep 29. Mult Scler. 2009. PMID: 19797261 Clinical Trial.

7

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

Nos C, Sastre-Garriga J, Borràs C, Río J, Tintoré M, Montalban X. Nos C, et al. Among authors: borras c. Mult Scler. 2004 Aug;10(4):413-6. doi: 10.1191/1352458504ms1068oa. Mult Scler. 2004. PMID: 15327039

8

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Tintoré M, Rovira A, Martínez MJ, Rio J, Díaz-Villoslada P, Brieva L, Borrás C, Grivé E, Capellades J, Montalban X. Tintoré M, et al. Among authors: borras c. AJNR Am J Neuroradiol. 2000 Apr;21(4):702-6. AJNR Am J Neuroradiol. 2000. PMID: 10782781 Free PMC article.

9

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.

Tintoré M, Rovira A, Brieva L, Grivé E, Jardí R, Borrás C, Montalban X. Tintoré M, et al. Among authors: borras c. Mult Scler. 2001 Dec;7(6):359-63. doi: 10.1177/135245850100700603. Mult Scler. 2001. PMID: 11795456

10

Late-onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: compound heterozygosity for the IVS2+1G-->A mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family.

Comabella M, Waye JS, Raguer N, Eng B, Domínguez C, Navarro C, Borrás C, Krivit W, Montalbán X. Comabella M, et al. Among authors: borras c. Ann Neurol. 2001 Jul;50(1):108-12. Ann Neurol. 2001. PMID: 11456299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters